Cargando…
The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both
The aryl hydrocarbon receptor (AHR) has long been studied by toxicologists as a ligand-activated transcription factor that is activated by dioxin and other environmental pollutants such as polycyclic aromatic hydrocarbons (PAHs). The hallmark of AHR activation is the upregulation of the cytochrome P...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183121/ https://www.ncbi.nlm.nih.gov/pubmed/25324842 http://dx.doi.org/10.3389/fimmu.2014.00458 |
_version_ | 1782337666858090496 |
---|---|
author | Julliard, Walker Fechner, John H. Mezrich, Joshua D. |
author_facet | Julliard, Walker Fechner, John H. Mezrich, Joshua D. |
author_sort | Julliard, Walker |
collection | PubMed |
description | The aryl hydrocarbon receptor (AHR) has long been studied by toxicologists as a ligand-activated transcription factor that is activated by dioxin and other environmental pollutants such as polycyclic aromatic hydrocarbons (PAHs). The hallmark of AHR activation is the upregulation of the cytochrome P450 enzymes that metabolize many of these toxic compounds. However, recent findings demonstrate that both exogenous and endogenous AHR ligands can alter innate and adaptive immune responses including effects on T-cell differentiation. Kynurenine, a tryptophan breakdown product, is one such endogenous ligand of the AHR. Expression of indoleamine 2,3-dioxygenase by dendritic cells causes accumulation of kynurenine and results in subsequent tolerogenic effects including increased regulatory T-cell activity. At the same time, PAHs found in pollution enhance Th17 differentiation in the lungs of exposed mice via the AHR. In this perspective, we will discuss the importance of the AHR in the immune system and the role this might play in normal physiology and response to disease. |
format | Online Article Text |
id | pubmed-4183121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-41831212014-10-16 The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both Julliard, Walker Fechner, John H. Mezrich, Joshua D. Front Immunol Immunology The aryl hydrocarbon receptor (AHR) has long been studied by toxicologists as a ligand-activated transcription factor that is activated by dioxin and other environmental pollutants such as polycyclic aromatic hydrocarbons (PAHs). The hallmark of AHR activation is the upregulation of the cytochrome P450 enzymes that metabolize many of these toxic compounds. However, recent findings demonstrate that both exogenous and endogenous AHR ligands can alter innate and adaptive immune responses including effects on T-cell differentiation. Kynurenine, a tryptophan breakdown product, is one such endogenous ligand of the AHR. Expression of indoleamine 2,3-dioxygenase by dendritic cells causes accumulation of kynurenine and results in subsequent tolerogenic effects including increased regulatory T-cell activity. At the same time, PAHs found in pollution enhance Th17 differentiation in the lungs of exposed mice via the AHR. In this perspective, we will discuss the importance of the AHR in the immune system and the role this might play in normal physiology and response to disease. Frontiers Media S.A. 2014-10-02 /pmc/articles/PMC4183121/ /pubmed/25324842 http://dx.doi.org/10.3389/fimmu.2014.00458 Text en Copyright © 2014 Julliard, Fechner and Mezrich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Julliard, Walker Fechner, John H. Mezrich, Joshua D. The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title | The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title_full | The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title_fullStr | The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title_full_unstemmed | The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title_short | The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both |
title_sort | aryl hydrocarbon receptor meets immunology: friend or foe? a little of both |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183121/ https://www.ncbi.nlm.nih.gov/pubmed/25324842 http://dx.doi.org/10.3389/fimmu.2014.00458 |
work_keys_str_mv | AT julliardwalker thearylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth AT fechnerjohnh thearylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth AT mezrichjoshuad thearylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth AT julliardwalker arylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth AT fechnerjohnh arylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth AT mezrichjoshuad arylhydrocarbonreceptormeetsimmunologyfriendorfoealittleofboth |